Atlas Trials

Safety Study of Pyridostigmine in Heart Failure

Clinical trial NCT01415921 · COMPLETED

Trial details

NCT number
NCT01415921
Sponsor
NYU Langone Health
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Heart Failure
Start date
2011-10-01
Primary completion
2015-07-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.